Sandbox GGC5: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Student (talk | contribs)
No edit summary
Student (talk | contribs)
No edit summary
Line 12: Line 12:


On the cellular level, titin is typically located within the nucleus of the cell; however, it can also be located within the cytoplasm.
On the cellular level, titin is typically located within the nucleus of the cell; however, it can also be located within the cytoplasm.
Protein kinase, including titin kinase, is a vital aspect of controlling cell proliferation and cell differentiation. Titin kinase is expressed in muscles and is responsible for the interaction with thick filaments known as myosin filaments. The enzymatic activity of protein kinases must be highly regulated through the phosphorylation of specific residues located in the activation component of the catalytic domain. Titin kinase is regulated in a two-step process including the partial unfolding of an inhibitory segment to expose the catalytic region followed by the phosphorylation of the Tyrosin residue. This tyrosine residue is depicted in the structural highlights listed below. <ref>PMID:19108772</ref>,<ref>PMID:9804419</ref>


== '''Disease''' ==
== '''Disease''' ==
'''Myopathy, myofibrillar, 9, with early respiratory failure:'''
'''Myopathy, myofibrillar, 9, with early respiratory failure:'''


This disease is characterized by adult onset of weakness in proximal, distal, axial and respiratory muscles. The main symptoms of onset are pelvic girdle and neck weakness. Ultimately, the weakness will affect the proximal compartment of both the upper and lower limbs. Additional symptoms include varying degrees of Achilles tendon contractures, spinal rigidity and muscle hypertrophy. In extreme cases, respiratory involvement will often lead to the requirement for non-invasive treatment. The natural variant indicating this disease can be found at position 279 and it disrupts NBR1-binding. <ref>PMID:15802564</ref>
This disease is characterized by adult onset of weakness in proximal, distal, axial and respiratory muscles. The main symptoms of onset are pelvic girdle and neck weakness. Ultimately, the weakness will affect the proximal compartment of both the upper and lower limbs. Additional symptoms include varying degrees of Achilles tendon contractures, spinal rigidity and muscle hypertrophy. In extreme cases, respiratory involvement will often lead to the requirement for non-invasive treatment. The natural variant indicating this disease can be found at position 279 and it disrupts NBR1-binding. <ref>PMID:15802564</ref>  


'''Cardiomyopathy, familial hypertrophic 9:'''
'''Cardiomyopathy, familial hypertrophic 9:'''

Revision as of 05:34, 5 November 2020

Titin

Caption for this structure

Drag the structure with the mouse to rotate

References